Phone: (011) 7541-421, 3409-301, 3409-335, 6547-293, 3409-310
E-mail: Standards sales: prodaja@iss.rs Education: iss-edukacija@iss.rs Information about standards: infocentar@iss.rs
Stevana Brakusa 2, 11030 Beograd
Main menu

SRPS EN ISO 15197:2017

In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197:2013)

Jan 31, 2017

General information

60.60     Jan 31, 2017

ISS

Z076

European Norm

11.100.10  

English  

Buying

Published

Language in which you want to receive the document.

Scope

ISO 15197:2013 specifies requirements for in vitro glucose monitoring systems that measure glucose concentrations in capillary blood samples, for specific design verification procedures and for the validation of performance by the intended users. These systems are intended for self-measurement by lay persons for management of diabetes mellitus.
ISO 15197:2013 is applicable to manufacturers of such systems and those other organizations (e.g. regulatory authorities and conformity assessment bodies) having the responsibility for assessing the performance of these systems.

Related directives

NOTE: If the word "harmonized" (marked in green) is not found in the field with the name of the directive, it means that the European standard is not cited in the OJEU.

98/79/EC

In vitro diagnostic medical devices

Harmonized

Life cycle

PREVIOUSLY

WITHDRAWN
SRPS EN ISO 15197:2014

NOW

PUBLISHED
SRPS EN ISO 15197:2017
60.60 Standard published
Jan 31, 2017

REVISED BY

PROJECT
prSRPS EN ISO 15197:2024

Related project

Adopted from EN ISO 15197:2015

Adopted from ISO 15197:2013